Health
Fluvoxamine may prevent serious illness in COVID-19 patients – China.org.cn
CHICAGO, Nov. 13 (Xinhua) — Researchers at Washington University School of Medicine in St. Louis have found in a preliminary study that the drug fluvoxamine seems to prevent some of the most serious complications of COVID-19 patients and make hospitalization and the need for supplemental oxygen less likely.
In an innovative twist to research during the pandemic, the study, involving 152 patients infected with SAR-CoV-2, the virus that causes COVID-19, was conducted remotely. When a symptomatic…
-
General23 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News17 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News16 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News19 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards